Cognitive impairment in heart failure patients: association with abnormal circadian blood pressure rhythm: a review from the HOPE Asia Network.
Blood pressure
Circadian rhythm
Cognitive impairment
Heart failure
Journal
Hypertension research : official journal of the Japanese Society of Hypertension
ISSN: 1348-4214
Titre abrégé: Hypertens Res
Pays: England
ID NLM: 9307690
Informations de publication
Date de publication:
26 Sep 2023
26 Sep 2023
Historique:
received:
13
04
2023
accepted:
10
08
2023
revised:
07
08
2023
medline:
26
9
2023
pubmed:
26
9
2023
entrez:
25
9
2023
Statut:
aheadofprint
Résumé
Cognitive impairment (CI) is frequently a comorbid condition in heart failure (HF) patients, and is associated with increased cardiovascular events and death. Numerous factors contribute to CI in HF patients. Decreased cerebral blood flow, inflammation, and activation of neurohumoral factors are all thought to be factors that exacerbate CI. Hypoperfusion of the brain due to decreased systemic blood flow, cerebral venous congestion, and atherosclerosis are the main mechanism of CI in HF patients. Abnormal circadian BP rhythm is one of the other conditions associated with CI. The conditions in which BP does not decrease sufficiently or increases during the night are called non-dipper or riser BP patterns. Abnormal circadian BP rhythm worsens CI in HF patients through cerebral congestion during sleep and atherosclerosis due to pressure overload. Interventions for CI in HF patients include treatment for HF itself using cardiovascular drugs, and treatment for fluid retention, one of the causes of abnormal circadian rhythms. Proposed pathways of cognitive impairment in heart failure through abnormal circadian blood pressure rhythm.
Identifiants
pubmed: 37749335
doi: 10.1038/s41440-023-01423-7
pii: 10.1038/s41440-023-01423-7
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Investigateurs
Ji-Guang Wang
(JG)
Yook-Chin Chia
(YC)
Peera Buranakitjaroen
(P)
Chen-Huan Chen
(CH)
Hao-Min Cheng
(HM)
Takeshi Fujiwara
(T)
Yan Li
(Y)
Minh Van Huynh
(M)
Michiaki Nagai
(M)
Jennifer Nailes
(J)
Sungha Park
(S)
Markus Schlaich
(M)
Jinho Shin
(J)
Saulat Siddique
(S)
Jorge Sison
(J)
Arieska Ann Soenarta
(AA)
Apichard Sukonthasarn
(A)
Jam Chin Tay
(JC)
Boon Wee Teo
(BW)
Kelvin Tsoi
(K)
Yuda Turana
(Y)
Narsingh Verma
(N)
Tzung-Dau Wang
(TD)
Yuqing Zhang
(Y)
Informations de copyright
© 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
Références
Okura Y, Ramadan MM, Ohno Y, Mitsuma W, Tanaka K, Ito M, et al. Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J. 2008;72:489–91.
pubmed: 18296852
doi: 10.1253/circj.72.489
Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation 2022;145:e153–e639.
pubmed: 35078371
doi: 10.1161/CIR.0000000000001052
Bahrami H, Kronmal R, Bluemke DA, Olson J, Shea S, Liu K, et al. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med. 2008;168:2138–45.
pubmed: 18955644
pmcid: 3038918
doi: 10.1001/archinte.168.19.2138
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–22.
doi: 10.1016/S0140-6736(20)30925-9
Bragazzi NL, Zhong W, Shu J, Abu Much A, Lotan D, Grupper A, et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol. 2021;28:1682–90.
pubmed: 33571994
doi: 10.1093/eurjpc/zwaa147
United Nations. World Population Ageing 2019. https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Report.pdf . Accessed June 18.
Alzheimer’s Disease International. Dementia in the Asia Pacific Region. https://www.alzint.org/resource/dementia-in-the-asia-pacific-region/ . Accessed June 20.
Alosco ML, Spitznagel MB, van Dulmen M, Raz N, Cohen R, Sweet LH, et al. Cognitive function and treatment adherence in older adults with heart failure. Psychosom Med. 2012;74:965–73.
pubmed: 23115344
pmcid: 3498588
doi: 10.1097/PSY.0b013e318272ef2a
Cameron J, Worrall-Carter L, Page K, Riegel B, Lo SK, Stewart S. Does cognitive impairment predict poor self-care in patients with heart failure? Eur J Heart Fail. 2010;12:508–15.
pubmed: 20354031
doi: 10.1093/eurjhf/hfq042
Kario K, Network tHA. The HOPE Asia Network for “zero” cardiovascular events in Asia. J Clin Hypertens (Greenwich). 2018;20:212–4.
pubmed: 29462507
doi: 10.1111/jch.13185
Angeli F, Reboldi G, Verdecchia P. The 2014 hypertension guidelines: implications for patients and practitioners in Asia. Heart Asia. 2015;7:21–5.
pubmed: 27326216
pmcid: 4832787
doi: 10.1136/heartasia-2015-010639
Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertension. J Hypertens. 2008;26:1636–41.
pubmed: 18622243
doi: 10.1097/HJH.0b013e3283018333
Havakuk O, King KS, Grazette L, Yoon AJ, Fong M, Bregman N, et al. Heart failure-induced brain injury. J Am Coll Cardiol. 2017;69:1609–16.
pubmed: 28335844
doi: 10.1016/j.jacc.2017.01.022
Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail. 2007;9:440–9.
pubmed: 17174152
doi: 10.1016/j.ejheart.2006.11.001
Hajduk AM, Kiefe CI, Person SD, Gore JG, Saczynski JS. Cognitive change in heart failure: a systematic review. Circ Cardiovasc Qual Outcomes. 2013;6:451–60.
pubmed: 23838109
doi: 10.1161/CIRCOUTCOMES.113.000121
Zuccala G, Marzetti E, Cesari M, Lo Monaco MR, Antonica L, Cocchi A, et al. Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey. Am J Med. 2005;118:496–502.
pubmed: 15866252
doi: 10.1016/j.amjmed.2005.01.030
Alosco ML, Brickman AM, Spitznagel MB, Garcia SL, Narkhede A, Griffith EY, et al. Cerebral perfusion is associated with white matter hyperintensities in older adults with heart failure. Congest Heart Fail. 2013;19:E29–34.
pubmed: 23517434
pmcid: 3692594
doi: 10.1111/chf.12025
Zuccala G, Onder G, Pedone C, Carosella L, Pahor M, Bernabei R, et al. Hypotension and cognitive impairment: selective association in patients with heart failure. Neurology. 2001;57:1986–92.
pubmed: 11739814
doi: 10.1212/WNL.57.11.1986
Hoth KF, Poppas A, Moser DJ, Paul RH, Cohen RA. Cardiac dysfunction and cognition in older adults with heart failure. Cogn Behav Neurol. 2008;21:65–72.
pubmed: 18541980
doi: 10.1097/WNN.0b013e3181799dc8
Roy B, Woo MA, Wang DJJ, Fonarow GC, Harper RM, Kumar R. Reduced regional cerebral blood flow in patients with heart failure. Eur J Heart Fail. 2017;19:1294–302.
pubmed: 28560737
doi: 10.1002/ejhf.874
Frey A, Sell R, Homola GA, Malsch C, Kraft P, Gunreben I, et al. Cognitive deficits and related brain lesions in patients with chronic heart failure. JACC Heart Fail. 2018;6:583–92.
pubmed: 29885954
doi: 10.1016/j.jchf.2018.03.010
Frey A, Homola GA, Henneges C, Mühlbauer L, Sell R, Kraft P, et al. Temporal changes in total and hippocampal brain volume and cognitive function in patients with chronic heart failure-the COGNITION.MATTERS-HF cohort study. Eur Heart J. 2021;42:1569–78.
pubmed: 33496311
pmcid: 8060058
doi: 10.1093/eurheartj/ehab003
Georgiadis D, Sievert M, Cencetti S, Uhlmann F, Krivokuca M, Zierz S, et al. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur Heart J. 2000;21:407–13.
pubmed: 10666355
doi: 10.1053/euhj.1999.1742
Erkelens CD, van der Wal HH, de Jong BM, Elting JW, Renken R, Gerritsen M, et al. Dynamics of cerebral blood flow in patients with mild non-ischaemic heart failure. Eur J Heart Fail. 2017;19:261–8.
pubmed: 27862767
doi: 10.1002/ejhf.660
Goh FQ, Kong WKF, Wong RCC, Chong YF, Chew NWS, Yeo TC, et al. Cognitive impairment in heart failure-a review. Biol (Basel). 2022;11:179.
Sung SH, Lee CW, Wang PN, Lee HY, Chen CH, Chung CP. Cognitive functions and jugular venous reflux in severe mitral regurgitation: a pilot study. PLoS One. 2019;14:e0207832.
pubmed: 30794544
pmcid: 6386300
doi: 10.1371/journal.pone.0207832
Fulop GA, Tarantini S, Yabluchanskiy A, Molnar A, Prodan CI, Kiss T, et al. Role of age-related alterations of the cerebral venous circulation in the pathogenesis of vascular cognitive impairment. Am J Physiol Heart Circ Physiol. 2019;316:H1124–H40.
pubmed: 30848677
pmcid: 6580383
doi: 10.1152/ajpheart.00776.2018
Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L. Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med. 2006;166:1003–8.
pubmed: 16682574
doi: 10.1001/archinte.166.9.1003
Adelborg K, Horvath-Puho E, Ording A, Pedersen L, Sorensen HT, Henderson VW. Heart failure and risk of dementia: a Danish nationwide population-based cohort study. Eur J Heart Fail. 2017;19:253–60.
pubmed: 27612177
doi: 10.1002/ejhf.631
Alosco ML, Brickman AM, Spitznagel MB, van Dulmen M, Raz N, Cohen R, et al. The independent association of hypertension with cognitive function among older adults with heart failure. J Neurol Sci. 2012;323:216–20.
pubmed: 23026535
pmcid: 3483380
doi: 10.1016/j.jns.2012.09.019
Alosco ML, Spitznagel MB, Cohen R, Sweet LH, Josephson R, Hughes J, et al. Obesity and cognitive dysfunction in heart failure: the role of hypertension, type 2 diabetes, and physical fitness. Eur J Cardiovasc Nurs. 2015;14:334–41.
pubmed: 24829294
doi: 10.1177/1474515114535331
Huffman JC, Celano CM, Beach SR, Motiwala SR, Januzzi JL. Depression and cardiac disease: epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol. 2013;2013:695925.
pubmed: 23653854
pmcid: 3638710
doi: 10.1155/2013/695925
Karlamangla AS, Singer BH, Greendale GA, Seeman TE. Increase in epinephrine excretion is associated with cognitive decline in elderly men: MacArthur studies of successful aging. Psychoneuroendocrinology 2005;30:453–60.
pubmed: 15721057
doi: 10.1016/j.psyneuen.2004.11.004
Athilingam P, Moynihan J, Chen L, D’Aoust R, Groer M, Kip K. Elevated levels of interleukin 6 and C-reactive protein associated with cognitive impairment in heart failure. Congest Heart Fail. 2013;19:92–8.
pubmed: 23057677
doi: 10.1111/chf.12007
Almeida OP, Garrido GJ, Beer C, Lautenschlager NT, Arnolda L, Flicker L. Cognitive and brain changes associated with ischaemic heart disease and heart failure. Eur Heart J. 2012;33:1769–76.
pubmed: 22296945
doi: 10.1093/eurheartj/ehr467
Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001;38:852–7.
pubmed: 11641298
doi: 10.1161/hy1001.092640
Chokesuwattanaskul A, Cheungpasitporn W, Thongprayoon C, Vallabhajosyula S, Bathini T, Mao MA, et al. Impact of circadian blood pressure pattern on silent cerebral small vessel disease: a systematic review and meta-analysis. J Am Heart Assoc. 2020;9:e016299.
pubmed: 32476573
pmcid: 7429026
doi: 10.1161/JAHA.119.016299
Ohya Y, Ohtsubo T, Tsuchihashi T, Eto K, Sadanaga T, Nagao T, et al. Altered diurnal variation of blood pressure in elderly subjects with decreased activity of daily living and impaired cognitive function. Hypertens Res. 2001;24:655–61.
pubmed: 11768724
doi: 10.1291/hypres.24.655
Guo H, Tabara Y, Igase M, Yamamoto M, Ochi N, Kido T, et al. Abnormal nocturnal blood pressure profile is associated with mild cognitive impairment in the elderly: the J-SHIPP study. Hypertens Res. 2010;33:32–6.
pubmed: 19851324
doi: 10.1038/hr.2009.172
Komori T, Eguchi K, Saito T, Nishimura Y, Hoshide S, Kario K. Riser blood pressure pattern is associated with mild cognitive impairment in heart failure patients. Am J Hypertens. 2016;29:194–201.
pubmed: 26066331
doi: 10.1093/ajh/hpv086
Yano Y, Butler KR, Hall ME, Schwartz GL, Knopman DS, Lirette ST, et al. Associations of nocturnal blood pressure with cognition by self-identified race in middle-aged and older adults: the GENOA (Genetic Epidemiology Network of Arteriopathy) study. J Am Heart Assoc. 2017;6:e007022.
pubmed: 29079569
pmcid: 5721781
doi: 10.1161/JAHA.117.007022
Ghazi L, Yaffe K, Tamura MK, Rahman M, Hsu CY, Anderson AH, et al. Association of 24-hour ambulatory blood pressure patterns with cognitive function and physical functioning in CKD. Clin J Am Soc Nephrol. 2020;15:455–64.
pubmed: 32217634
pmcid: 7133123
doi: 10.2215/CJN.10570919
Xing Y, Sun Y, Wang S, Feng F, Zhang D, Li H. Nocturnal blood pressure rise as a predictor of cognitive impairment among the elderly: a retrospective cohort study. BMC Geriatr. 2021;21:462.
pubmed: 34380417
pmcid: 8359081
doi: 10.1186/s12877-021-02406-4
Xu Y, Gong C, Liao J, Ge Z, Tan Y, Jiang Y, et al. Absence of fluctuation and inverted circadian rhythm of blood pressure increase the risk of cognitive dysfunction in cerebral small vessel disease patients. BMC Neurol. 2023;23:73.
pubmed: 36793019
pmcid: 9930256
doi: 10.1186/s12883-023-03107-8
Goyal D, Macfadyen RJ, Watson RD, Lip GYH. Ambulatory blood pressure monitoring in heart failure: a systematic review. Eur J Heart Fail. 2005;7:149–56.
pubmed: 15701460
doi: 10.1016/j.ejheart.2004.05.010
Komori T, Eguchi K, Saito T, Hoshide S, Kario K. Riser pattern is a novel predictor of adverse events in heart failure patients with preserved ejection fraction. Circ J. 2017;81:220–6.
pubmed: 28025460
doi: 10.1253/circj.CJ-16-0740
Komori T, Hoshide S, Kario K. Differential effect of the morning blood pressure surge on prognoses between heart failure with reduced and preserved ejection fractions. Circ J. 2021;85:1535–42.
pubmed: 33853990
doi: 10.1253/circj.CJ-20-0972
Ueda T, Kawakami R, Nakada Y, Nakano T, Nakagawa H, Matsui M, et al. Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction. ESC Heart Fail. 2019;6:1057–67.
pubmed: 31325235
pmcid: 6816074
doi: 10.1002/ehf2.12500
Komori T, Hoshide S, Tabei KI, Tomimoto H, Kario K. Quantitative evaluation of white matter hyperintensities in patients with heart failure using an innovative magnetic resonance image analysis method: association with disrupted circadian blood pressure variation. J Clin Hypertens (Greenwich). 2021;23:1089–92.
pubmed: 33538394
doi: 10.1111/jch.14204
Otsuka A, Mikami H, Katahira K, Nakamoto Y, Minamitani K, Imaoka M, et al. Absence of nocturnal fall in blood pressure in elderly persons with Alzheimer-type dementia. J Am Geriatr Soc. 1990;38:973–8.
pubmed: 2212450
doi: 10.1111/j.1532-5415.1990.tb04418.x
Kitamura J, Nagai M, Ueno H, Ohshita T, Kikumoto M, Toko M, et al. The insular cortex, Alzheimer disease pathology, and their effects on blood pressure variability. Alzheimer Dis Assoc Disord. 2020;34:282–91.
pubmed: 32384285
doi: 10.1097/WAD.0000000000000340
Nagai M, Kato M, Dote K. Orthostatic hypotension with nondipping: phenotype of neurodegenerative disease. Hypertens Res. 2022;45:1514–6.
pubmed: 35836000
doi: 10.1038/s41440-022-00980-7
Lanfranchi PA, Pennestri MH, Fradette L, Dumont M, Morin CM, Montplaisir J. Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. Sleep. 2009;32:760–6.
pubmed: 19544752
pmcid: 2690563
doi: 10.1093/sleep/32.6.760
Lovell J, Pham T, Noaman SQ, Davis M-C, Johnson M, Ibrahim JE. Self-management of heart failure in dementia and cognitive impairment: a systematic review. BMC Cardiovasc Disord. 2019;19:99.
pubmed: 31035921
pmcid: 6489234
doi: 10.1186/s12872-019-1077-4
Dolansky MA, Hawkins MAW, Schaefer JT, Sattar A, Gunstad J, Redle JD, et al. Association between poorer cognitive function and reduced objectively monitored medication adherence in patients with heart failure. Circ Heart Fail. 2016;9:e002475.
pubmed: 27895069
pmcid: 5131517
doi: 10.1161/CIRCHEARTFAILURE.116.002475
Kewcharoen J, Trongtorsak A, Kanitsoraphan C, Prasitlumkum N, Mekritthikrai R, Techorueangwiwat C, et al. Cognitive impairment and 30-day rehospitalization rate in patients with acute heart failure: a systematic review and meta-analysis. Indian Heart J. 2019;71:52–9.
pubmed: 31000183
pmcid: 6477121
doi: 10.1016/j.ihj.2018.12.006
Lan H, Hawkins LA, Kashner M, Perez E, Firek CJ, Silvet H. Cognitive impairment predicts mortality in outpatient veterans with heart failure. Heart Lung. 2018;47:546–52.
pubmed: 30143364
doi: 10.1016/j.hrtlng.2018.06.008
Zuccala G, Onder G, Marzetti E, Monaco MR, Cesari M, Cocchi A, et al. Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure. Eur Heart J. 2005;26:226–33.
pubmed: 15618043
doi: 10.1093/eurheartj/ehi058
Low S, Goh KS, Ng TP, Moh A, Ang SF, Wang J, et al. Association between use of sodium-glucose co-transporter-2 (SGLT2) inhibitors and cognitive function in a longitudinal study of patients with type 2 diabetes. J Alzheimers Dis. 2022;87:635–42.
pubmed: 35342091
doi: 10.3233/JAD-215678
Mui JV, Zhou J, Lee S, Leung KSK, Lee TTL, Chou OHI, et al. Sodium-glucose cotransporter 2 (SGLT2) inhibitors vs. dipeptidyl peptidase-4 (DPP4) inhibitors for new-onset dementia: a propensity score-matched population-based study with competing risk analysis. Front Cardiovasc Med. 2021;8:747620.
pubmed: 34746262
pmcid: 8566991
doi: 10.3389/fcvm.2021.747620
Cannon JA, Shen L, Jhund PS, Kristensen SL, Kober L, Chen F, et al. Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction. Eur J Heart Fail. 2017;19:129–37.
pubmed: 27868321
doi: 10.1002/ejhf.687
Li M, Zheng C, Kawada T, Inagaki M, Uemura K, Sugimachi M. Adding the acetylcholinesterase inhibitor, donepezil, to losartan treatment markedly improves long-term survival in rats with chronic heart failure. Eur J Heart Fail. 2014;16:1056–65.
pubmed: 25201490
doi: 10.1002/ejhf.164
Li M, Zheng C, Kawada T, Uemura K, Inagaki M, Saku K, et al. Early donepezil monotherapy or combination with metoprolol significantly prevents subsequent chronic heart failure in rats with reperfused myocardial infarction. J Physiol Sci. 2022;72:12.
pubmed: 35725377
doi: 10.1186/s12576-022-00836-2
Hsieh MJ, Chen DY, Lee CH, Wu CL, Chen YJ, Huang YT, et al. Association between cholinesterase inhibitors and new-onset heart failure in patients with Alzheimer’s disease: a nationwide propensity score matching study. Front Cardiovasc Med. 2022;9:831730.
pubmed: 35369359
pmcid: 8966646
doi: 10.3389/fcvm.2022.831730
Kubo T, Sato T, Noguchi T, Kitaoka H, Yamasaki F, Kamimura N, et al. Influences of donepezil on cardiovascular system-possible therapeutic benefits for heart failure-donepezil cardiac test registry (DOCTER) study. J Cardiovasc Pharm. 2012;60:310–4.
doi: 10.1097/FJC.0b013e3182609a74
Tanne D, Freimark D, Poreh A, Merzeliak O, Bruck B, Schwammenthal Y, et al. Cognitive functions in severe congestive heart failure before and after an exercise training program. Int J Cardiol. 2005;103:145–9.
pubmed: 16080972
doi: 10.1016/j.ijcard.2004.08.044
Karlsson MR, Edner M, Henriksson P, Mejhert M, Persson H, Grut M, et al. A nurse-based management program in heart failure patients affects females and persons with cognitive dysfunction most. Patient Educ Couns. 2005;58:146–53.
pubmed: 16009290
doi: 10.1016/j.pec.2004.08.005
Fumagalli S, Pieragnoli P, Ricciardi G, Mascia G, Mascia F, Michelotti F, et al. Cardiac resynchronization therapy improves functional status and cognition. Int J Cardiol. 2016;219:212–7.
pubmed: 27332741
doi: 10.1016/j.ijcard.2016.06.001
Bhat G, Yost G, Mahoney E. Cognitive function and left ventricular assist device implantation. J Heart Lung Transpl. 2015;34:1398–405.
doi: 10.1016/j.healun.2015.05.015
Roman DD, Kubo SH, Ormaza S, Francis GS, Bank AJ, Shumway SJ. Memory improvement following cardiac transplantation. J Clin Exp Neuropsychol. 1997;19:692–7.
pubmed: 9408799
doi: 10.1080/01688639708403754
Sherafati A, Tootoonchian MJ, Eslami M, Najafi MT, Mollazadeh R. Effect of cardiac resynchronization therapy on ambulatory blood pressure monitoring indices in patients with heart failure and hypertension. Blood Press Monit. 2021;26:385–7.
pubmed: 34074805
doi: 10.1097/MBP.0000000000000550
Castagna F, McDonnell BJ, Mondellini GM, Gaudig A, Pinsino A, McEniery C, et al. Twenty-four-hour blood pressure and heart rate variability are reduced in patients on left ventricular assist device support. J Heart Lung Transpl. 2022;41:802–9.
doi: 10.1016/j.healun.2022.02.016
Hermida RC, Mojón A, Fernández JR, Hermida-Ayala RG, Crespo JJ, Ríos MT, et al. Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: a review of the published literature. Chronobiol Int. 2023;40:63–82.
pubmed: 34190016
doi: 10.1080/07420528.2021.1939367
Kimura G. Kidney and circadian blood pressure rhythm. Hypertension. 2008;51:827–8.
pubmed: 18316650
doi: 10.1161/HYPERTENSIONAHA.108.110213
Katsuya T, Ishikawa K, Sugimoto K, Rakugi H, Ogihara T. Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res. 2003;26:521–5.
pubmed: 12924618
doi: 10.1291/hypres.26.521
Cicconetti P, Ciotti V, Monteforte G, Moise A, Chiarotti F, Piccirillo G, et al. Circadian blood pressure pattern and cognitive function in newly diagnosed older hypertensives. Blood Press. 2003;12:168–74.
pubmed: 12875479
doi: 10.1080/08037050310011821